Showing 1 - 2 results of 2 for search 'Huw Roddie', query time: 0.02s Refine Results
  1. 1
    Phase II study of bortezomib–dexamethasone alone or with added cyclophosphamide or lenalidomide for sub-optimal response as second-line treatment for patients with multiple myeloma

    Phase II study of bortezomib–dexamethasone alone or with added cyclophosphamide or lenalidomide for sub-optimal response as second-line treatment for patients with multiple myeloma... by Meletios A. Dimopoulos, Meral Beksac, Lotfi Benboubker, Huw Roddie, Nathalie Allietta, Esther Broer, Catherine Couturier, Marie-Andrée Mazier, Ralf Angermund, Thierry Facon

    Published 2013-08-01
    Get full text
    Article
  2. 2
    Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma

    Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma by Meletios A. Dimopoulos, Robert Z. Orlowski, Thierry Facon, Pieter Sonneveld, Kenneth C. Anderson, Meral Beksac, Lotfi Benboubker, Huw Roddie, Anna Potamianou, Catherine Couturier, Huaibao Feng, Ozlem Ataman, Helgi van de Velde, Paul G. Richardson

    Published 2015-01-01
    Get full text
    Article

Search Tools: